查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1573888

醫療動畫市場、機會、成長動力、產業趨勢分析與預測，2024-2032

Medical Animation Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032
出版日期: | 出版商: Global Market Insights Inc. | 英文 208 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年，全球醫學動畫市場價值為 4.93 億美元，預計 2024 年至 2032 年複合年成長率為 19.3%。醫學動畫提供了一種有效的方式來視覺化複雜的醫學概念、程序和疾病，增強醫療保健專業人員和患者的理解。

3D 建模和虛擬實境 (VR) 的進步進一步推動了需求的成長，這些技術可以精確、真實地呈現醫療內容。此外，人工智慧帶來的變革提高了溝通效率，為市場創造了新的機會。對病患教育和參與的重視也促進了醫學動畫在臨床環境、醫療培訓和病患溝通中的採用。

醫學動畫是指用於描繪複雜的醫學概念、程序和解剖結構的數位表示。此過程包括創建詳細的、互動的、通常為 3D 的視覺化效果，以增強理解和溝通。醫學動畫服務於各種應用，包括醫學訓練的教育工具、病患教育材料和醫療產品的宣傳內容。

市場根據組件分為軟體和服務。預計軟體領域在預測期內將以 19.2% 的複合年成長率成長。該細分市場因其在創建、編輯和交付高品質視覺內容方面的重要作用而佔據市場主導地位。先進的動畫軟體可以開發詳細的互動式醫療視覺化，從而增強教育體驗，使其廣泛應用於醫療機構、製藥公司和教育平台。軟體功能的不斷進步，例如改進的 3D 渲染和 VR 整合，進一步鞏固了其市場地位。

就治療領域而言，市場包括腫瘤學、神經學、心臟病學、美容學、牙科等領域。由於需要先進的視覺工具來說明複雜的癌症機制和治療方案，腫瘤學領域在 2023 年佔據了最大的市場佔有率，達到 28.3%。

該市場還按應用分為藥物作用機制 (MOA)、患者教育、手術培訓、細胞研究和其他應用。藥物 MOA 領域預計到 2032 年將達到 9.578 億美元，這得益於其在展示複雜藥物交互作用和監管流程方面的關鍵作用。

從最終用戶來看，該市場包括醫院、學術機構、醫療器材製造商和製藥公司。製藥和生物技術領域佔據市場主導地位，2023 年銷售額為 1.867 億美元，主要歸功於技術進步。

在美國，2023 年醫療動畫市場價值為 2.02 億美元，預計到預測期結束時將達到 9.382 億美元。該國的突出地位得益於其先進的技術基礎設施、對研發的大量投資以及對加強醫學教育和患者參與的大力關注。

目錄

第 1 章：方法與範圍

第 2 章：執行摘要

第 3 章：產業洞察

  • 產業生態系統分析
  • 產業影響力
    • 成長動力
      • 醫學動畫的採用率不斷上升
      • 3D 建模和虛擬實境 (VR) 領域的技術進步
      • 越來越重視病患參與和教育
    • 產業陷阱與挑戰
      • 醫療動畫服務成本高
  • 成長潛力分析
  • 技術景觀
  • 監管環境
  • 波特的分析
  • PESTEL分析

第 4 章：競爭格局

  • 介紹
  • 公司矩陣分析
  • 主要市場參與者的競爭分析
  • 競爭定位矩陣
  • 戰略儀表板

第 5 章：市場估計與預測：按組成部分，2021 - 2032 年

  • 主要趨勢
  • 軟體
    • 2D動畫
    • 3D動畫
    • Flash動畫
    • 即時成像 (RTI)
    • 4D動畫
  • 服務

第 6 章：市場估計與預測：按治療領域，2021 - 2032 年

  • 主要趨勢
  • 腫瘤學
  • 神經病學
  • 心臟病學
  • 美容
  • 牙科
  • 其他治療領域

第 7 章：市場估計與預測：按應用分類 2021 - 2032

  • 主要趨勢
  • 藥物作用機轉（MOA）與核准
  • 病患教育
  • 手術培訓和計劃
  • 細胞和分子研究
  • 其他應用

第 8 章：市場估計與預測：按最終用戶分類，2021 - 2032 年

  • 主要趨勢
  • 醫院和診所
  • 學術及研究機構
  • 醫療器材製造商
  • 製藥和生物技術公司
  • 其他最終用戶

第 9 章：市場估計與預測：按地區，2021 - 2032

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 荷蘭
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地區
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 中東和非洲其他地區

第 10 章：公司簡介

  • Animated Biomedical Productions
  • Arifanimaker Animations and Graphics
  • AXS Studio
  • Elara Systems
  • Ghost Productions, Inc.
  • Healthed Pty Ltd
  • Hybrid Medical Animation
  • INFUSE MEDIA GROUP, LLC
  • Medmovie
  • Nucleus Medical Media
  • Random42 Scientific Communication
  • Scientific Animations
  • Visible Body
  • Visioglobe
  • Vessel Studios
簡介目錄
Product Code: 11116

The Global Medical Animation Market was valued at USD 493 million in 2023 and is expected to grow at a CAGR of 19.3% from 2024 to 2032. This growth is primarily driven by the increasing demand for visually engaging and interactive educational tools. Medical animations offer an effective way to visualize complex medical concepts, procedures, and diseases, enhancing understanding for both healthcare professionals and patients.

The rise in demand is further fueled by advancements in 3D modeling and virtual reality (VR), which allow for precise and realistic representations of medical content. Additionally, the transformation brought by artificial intelligence (AI) has improved communication effectiveness, creating new opportunities in the market. The emphasis on patient education and engagement is also boosting the adoption of medical animations in clinical settings, medical training, and patient communication.

Medical animation refers to digital representations used to depict intricate medical concepts, procedures, and anatomical structures. This process includes creating detailed, interactive, often 3D visualizations to enhance understanding and communication. Medical animations serve various applications, including educational tools for medical training, patient education materials, and promotional content for medical products.

The market is segmented based on components into software and services. The software segment is expected to grow at a CAGR of 19.2% during the forecast period. This segment dominates the market due to its vital role in creating, editing, and delivering high-quality visual content. Advanced animation software enables the development of detailed and interactive medical visualizations that enhance educational experiences, making it widely used across medical institutions, pharmaceutical companies, and educational platforms. Continuous advancements in software capabilities, such as improved 3D rendering and VR integration, further strengthen its market position.

In terms of therapeutic areas, the market includes oncology, neurology, cardiology, cosmetology, dental, and other areas. The oncology segment accounted for the largest market share at 28.3% in 2023, driven by the need for advanced visual tools to illustrate complex cancer mechanisms and treatment protocols.

The market is also segmented by application into drug mechanisms of action (MOA), patient education, surgical training, cellular studies, and other applications. The drug MOA segment is poised to reach USD 957.8 million by 2032, driven by its critical role in demonstrating complex drug interactions and regulatory processes.

Based on end-users, the market comprises hospitals, academic institutes, medical device manufacturers, and pharmaceutical companies. The pharmaceutical and biotechnology segment dominated the market, accounting for USD 186.7 million in 2023, primarily due to technological advancements.

In the U.S., the medical animation market was valued at USD 202 million in 2023 and is expected to reach USD 938.2 million by the end of the forecast period. The country's prominence is supported by its advanced technological infrastructure, substantial investment in research and development, and a strong focus on enhancing medical education and patient engagement.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising adoption of medical animation
      • 3.2.1.2 Technological advancements in 3D modelling and virtual reality (VR)
      • 3.2.1.3 Growing emphasis on patient engagement and education
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 High cost of medical animation services
  • 3.3 Growth potential analysis
  • 3.4 Technology landscape
  • 3.5 Regulatory landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Component, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Software
    • 5.2.1 2D animation
    • 5.2.2 3D animation
    • 5.2.3 Flash animation
    • 5.2.4 Real-time imaging (RTI)
    • 5.2.5 4D animation
  • 5.3 Services

Chapter 6 Market Estimates and Forecast, By Therapeutic Area, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Oncology
  • 6.3 Neurology
  • 6.4 Cardiology
  • 6.5 Cosmetology
  • 6.6 Dental
  • 6.7 Other therapeutic areas

Chapter 7 Market Estimates and Forecast, By Application 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Drug mechanism of action (MOA) and approval
  • 7.3 Patient education
  • 7.4 Surgical training and planning
  • 7.5 Cellular and molecular studies
  • 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End-User, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals and clinics
  • 8.3 Academic and research institutes
  • 8.4 Medical device manufacturers
  • 8.5 Pharmaceutical and biotechnology companies
  • 8.6 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Animated Biomedical Productions
  • 10.2 Arifanimaker Animations and Graphics
  • 10.3 AXS Studio
  • 10.4 Elara Systems
  • 10.5 Ghost Productions, Inc.
  • 10.6 Healthed Pty Ltd
  • 10.7 Hybrid Medical Animation
  • 10.8 INFUSE MEDIA GROUP, LLC
  • 10.9 Medmovie
  • 10.10 Nucleus Medical Media
  • 10.11 Random42 Scientific Communication
  • 10.12 Scientific Animations
  • 10.13 Visible Body
  • 10.14 Visioglobe
  • 10.15 Vessel Studios